AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 12, 2020 at 4:30 p.m. Eastern Time

March 4, 2020 GMT

GERMANTOWN, Md.--(BUSINESS WIRE)--Mar 4, 2020--

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system – the Eversense® CGM System – today announced that it plans to release its fourth quarter and full year 2019 financial results after market close on Thursday, March 12, 2020.

Management will hold a conference call to review the company’s fourth quarter 2019 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 877-883-0383 (US/Canada) or 412-902-6506 (International), passcode 5108232, approximately ten to five minutes prior to start time.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics’ CGM Systems, Eversense ® and Eversense ® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200304005791/en/

CONTACT: Senseonics Investor Contact

Lynn Lewis or Philip Taylor

Investor Relations

415-937-5406

investors@senseonics.comSenseonics Media Contact:

Karen Hynes

Public Relations

619-206-9811

Karen.hynes@senseonics.com

KEYWORD: MARYLAND UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: DIABETES HEALTH MEDICAL DEVICES

SOURCE: Senseonics Holdings, Inc.

Copyright Business Wire 2020.

PUB: 03/04/2020 04:05 PM/DISC: 03/04/2020 04:05 PM

http://www.businesswire.com/news/home/20200304005791/en